Volume 17, Issue 1 (Winter 2026)
Caspian J Intern Med 2026, 17(1): 52-58 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ding S, Ji C, Liu Z, Zhang H, Tian C, Wang C. Clinical efficacy and mechanism of action of cardiac rehabilitation after revascularization for multi-vessel
coronary artery disease. Caspian J Intern Med 2026; 17 (1) :52-58
URL: http://caspjim.com/article-1-4677-en.html
URL: http://caspjim.com/article-1-4677-en.html
Department of Cardiology, Huai'an Rehabilitation Hospital (Jinhu County People's Hospital), Huaian City, China , jsjhcardiology@aliyun.com
Abstract: (29 Views)
Background: Analyzing the clinical efficacy and mechanism of action of cardiac rehabilitation after revascularization for coronary multibranch lesions.
Methods: 150 patients with multiple coronary artery lesions were selected for the study from July 2022 to March 2023, and were randomly divided into observation group (75 cases, complete revascularization + cardiac rehabilitation intervention) and control group (75 cases, complete revascularization). The level of patients' 6 min walking experiment, quality of life, cardiac function indexes, and laboratory indexes were analyzed.
Results: The level of 6-min walking test was significantly higher in the observation group than in the control group (p<0.05); the quality of life of patients in the observation group was significantly higher than that of the control group (p<0.05); the levels of left ventricular end-systolic internal diameter (LVESD), left ventricular end-diastolic internal diameter (LVEDD), left ventricular pressure (LVP), and interventricular septal thickness (LVS) in patients in the observation group were significantly lower than that of the control group; and the level of LV ejection fraction (LVEFA) levels were significantly higher than those of the control group (P=0.00); serum homocysteine (Hcy) and blood uric acid (SUA) levels of patients in the observation group were significantly lower than those of the control group (P=0.00).
Conclusion: Complete revascularization + cardiac rehabilitation intervention can effectively improve patients' 6-min walking test level, improve patients' cardiac function indexes, improve patients' quality of life, improve patients' laboratory index levels, and play a significant role in improving patients' prognosis, which is worthy of widespread promotion.
Methods: 150 patients with multiple coronary artery lesions were selected for the study from July 2022 to March 2023, and were randomly divided into observation group (75 cases, complete revascularization + cardiac rehabilitation intervention) and control group (75 cases, complete revascularization). The level of patients' 6 min walking experiment, quality of life, cardiac function indexes, and laboratory indexes were analyzed.
Results: The level of 6-min walking test was significantly higher in the observation group than in the control group (p<0.05); the quality of life of patients in the observation group was significantly higher than that of the control group (p<0.05); the levels of left ventricular end-systolic internal diameter (LVESD), left ventricular end-diastolic internal diameter (LVEDD), left ventricular pressure (LVP), and interventricular septal thickness (LVS) in patients in the observation group were significantly lower than that of the control group; and the level of LV ejection fraction (LVEFA) levels were significantly higher than those of the control group (P=0.00); serum homocysteine (Hcy) and blood uric acid (SUA) levels of patients in the observation group were significantly lower than those of the control group (P=0.00).
Conclusion: Complete revascularization + cardiac rehabilitation intervention can effectively improve patients' 6-min walking test level, improve patients' cardiac function indexes, improve patients' quality of life, improve patients' laboratory index levels, and play a significant role in improving patients' prognosis, which is worthy of widespread promotion.
Policy Brief: Original Article |
Subject:
Cardiology
Received: 2025/01/28 | Accepted: 2025/07/13 | Published: 2026/01/11
Received: 2025/01/28 | Accepted: 2025/07/13 | Published: 2026/01/11
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |